Early hepatic artery thrombosis treatments and outcomes: aorto-hepatic arterial conduit interposition or revision of anastomosis?

Table 1 Demographic, surgical, and laboratory data of the included adult E-HAT (numerical variables are based on Median [95% confidence interval of mean])

Variable		Total (n = 37)	AHCI (n = 16)	Revision (n = 19) *
Age (years)		45.5 [38.8–47.7]	44 [37–50]	49 [36.6–51]
Male Sex, n (%)		59%	56%	68%
No. of HA Exploration		1 [1.1–1.6]	1	1 [1.1-2.0] **
MELD score		20 [18.3–22.4]	19 [15.8–24.6]	20 [18.5–22.8]
Liver weight (grams)		1150 [1050.9-1234.9]	1090 [945.5–1213]	1160 [1038.5-1329.5]
CIT (min)		480 [370.7-479.2]	450 [328–508]	480 [343.4-508.1]
ALP		244 [243.1-404.5]	198 [151.1-355.2]	331 [239.5-430.1]
Indications of OLT	HBV	13	4	9
	PSC	7	2	5
	HBV + HCC	4	3	1
	AIH	4	3	1
	Wilson	3	1	2
	NASH	2	0	2
	Cryptogenic	2	2	0
	NET	1	1	0
	ALF	1	0	1

AHCI: aorto-hepatic conduit interposition, AIH: autoimmune hepatitis, ALF: acute liver failure, ALP: alkaline phosphatase, CIT: cold ischemic time, HA: hepatic artery, HBV: hepatitis B virus, HCC: hepatocellular carcinoma, MELD: model for end stage liver disease, NASH: non-alcoholic steatohepatitis, NET: neuroendocrine tumor, PSC: primary sclerosing cholangitis, All comparisons were statistically insignificant except for mentioned variable with double stars
*Two patients from the revision group had in situ AHCI and are not included in the analysis
**The HA was explored for thrombosis one, two, three, and four times for 12, four, two, and one patient in the revision group, respectively

ISSN: 1471-2482